Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ingersoll

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Gynecologic Oncology|April 19, 2011
Tolfenamic acid inhibits ovarian cancer cell growth and decreases the expression of c-Met and survivin through suppressing specificity protein transcription factorsRiyaz Basha, Susan B Ingersoll, Umesh T Sankpal, et al.
Thrombosis and Haemostasis|June 22, 2005
The role of CD40 in CD40L- and antibody-mediated platelet activationFlorian Langer, Susan B Ingersoll, Ali Amirkhosravi, et al.
Brain Research|June 25, 1990
Anesthesia influences the outcome from experimental spinal cord injuryS K Salzman, A A Mendez, S Sabato, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 2, 2016
Association of Sp1 and survivin in epithelial ovarian cancer: Sp1 inhibitor and cisplatin, a novel combination for inhibiting epithelial ovarian cancer cell proliferationUmesh T Sankpal, Susan B Ingersoll, Sarfraz Ahmad, et al.
Molecular and Cellular Biochemistry|June 7, 2015
Cellular therapy in combination with cytokines improves survival in a xenograft mouse model of ovarian cancerSusan B Ingersoll, Sarfraz Ahmad, Hasina C McGann, et al.
Annals of Surgical Oncology|March 8, 2017
A Prospective Cohort Study Comparing Colorimetric and Fluorescent Imaging for Sentinel Lymph Node Mapping in Endometrial CancerRobert W Holloway, Sarfraz Ahmad, James E Kendrick, et al.
Journal of Neurotrauma|January 1, 1988
The somatosensory evoked potential predicts neurologic deficits and serotonergic pathochemistry after spinal distraction injury in experimental scoliosisS K Salzman, K W Dabney, A A Mendez, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Gynecologic Oncology|April 19, 2011
Tolfenamic acid inhibits ovarian cancer cell growth and decreases the expression of c-Met and survivin through suppressing specificity protein transcription factorsRiyaz Basha, Susan B Ingersoll, Umesh T Sankpal, et al.
Thrombosis and Haemostasis|June 22, 2005
The role of CD40 in CD40L- and antibody-mediated platelet activationFlorian Langer, Susan B Ingersoll, Ali Amirkhosravi, et al.
Brain Research|June 25, 1990
Anesthesia influences the outcome from experimental spinal cord injuryS K Salzman, A A Mendez, S Sabato, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 2, 2016
Association of Sp1 and survivin in epithelial ovarian cancer: Sp1 inhibitor and cisplatin, a novel combination for inhibiting epithelial ovarian cancer cell proliferationUmesh T Sankpal, Susan B Ingersoll, Sarfraz Ahmad, et al.
Molecular and Cellular Biochemistry|June 7, 2015
Cellular therapy in combination with cytokines improves survival in a xenograft mouse model of ovarian cancerSusan B Ingersoll, Sarfraz Ahmad, Hasina C McGann, et al.
Annals of Surgical Oncology|March 8, 2017
A Prospective Cohort Study Comparing Colorimetric and Fluorescent Imaging for Sentinel Lymph Node Mapping in Endometrial CancerRobert W Holloway, Sarfraz Ahmad, James E Kendrick, et al.
Journal of Neurotrauma|January 1, 1988
The somatosensory evoked potential predicts neurologic deficits and serotonergic pathochemistry after spinal distraction injury in experimental scoliosisS K Salzman, K W Dabney, A A Mendez, et al.
Pageof 4